Financial Results for Mar 31, 2010
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the Quarter & Year ended March 31, 2010.29-05-2010
Financial Results for Mar 31, 2010
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the Quarter & Year ended March 31, 2010.Board to consider Dividend
Bliss GVS Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 29, 2010, inter alia, to consider the Audited Financial Result for the year ended March 31, 2010 and dividend if any.Publish Audited Results
Bliss GVS Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on or before May 31, 2010 to consider and adopt the Audited Financial results for the quarter ended March 31, 2010.Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Shibroor N Kamath has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSEDisclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSEDisclosures under Reg. 7(1A) of SEBI (SAST) Regulations, 1997
Shibroor N Kamath has submitted the disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSEDisclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Bliss GVS Pharma Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSEBliss GVS - Financial Results for Dec 31, 2009
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2009.Bliss GVS - Outcome of Board Meeting
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 27, 2010, inter alia, has approved the appointment of Dr. Vibha N. Kamath as a Whole Time Director of the Company.